These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 26449843)

  • 21. Opioid-Related Constipation in Patients With Non-cancer Pain Syndromes: a Review of Evidence-Based Therapies and Justification for a Change in Nomenclature.
    Brenner DM; Stern E; Cash BD
    Curr Gastroenterol Rep; 2017 Mar; 19(3):12. PubMed ID: 28337726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic constipation: current treatment options.
    Liu LW
    Can J Gastroenterol; 2011 Oct; 25 Suppl B(Suppl B):22B-28B. PubMed ID: 22114754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of opioid-induced constipation for people in palliative care.
    Prichard D; Bharucha A
    Int J Palliat Nurs; 2015 Jun; 21(6):272, 274-80. PubMed ID: 26126675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    J Med Econ; 2015 Apr; 18(4):283-94. PubMed ID: 25333331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on the use of pharmacotherapy for opioid-induced bowel dysfunction.
    Mousavi T; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2023 Feb; 24(3):359-375. PubMed ID: 36548911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
    Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of constipation in palliative care patients.
    Clemens KE; Klaschik E
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):22-7. PubMed ID: 18685390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating Opioid-Induced Constipation in Older Adults: New Options.
    Sani H; Mahan RJ
    Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating constipation in palliative care: the impact of other factors aside from opioids.
    Clark K; Byfieldt N; Dawe M; Currow DC
    Am J Hosp Palliat Care; 2012 Mar; 29(2):122-5. PubMed ID: 21606123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L; Atayee R; Helmons P; von Gunten CF
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Constipation.
    Bharucha AE; Wald A
    Mayo Clin Proc; 2019 Nov; 94(11):2340-2357. PubMed ID: 31054770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological treatment of constipation in palliative care.
    Clemens KE; Faust M; Jaspers B; Mikus G
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):183-91. PubMed ID: 23478431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lubiprostone for the treatment of opioid-induced bowel dysfunction.
    Wong BS; Camilleri M
    Expert Opin Pharmacother; 2011 Apr; 12(6):983-90. PubMed ID: 21385112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
    Jamal MM; Adams AB; Jansen JP; Webster LR
    Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
    Kyle G
    Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constipation: pathophysiology and management.
    Wald A
    Curr Opin Gastroenterol; 2015 Jan; 31(1):45-9. PubMed ID: 25394234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constipation: Advances in Diagnosis and Treatment.
    Wald A
    JAMA; 2016 Jan; 315(2):185-91. PubMed ID: 26757467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.